Budget Impact Analysis of Preoperative Radioactive Seed Localization

  • PDF / 594,773 Bytes
  • 9 Pages / 595.276 x 790.866 pts Page_size
  • 37 Downloads / 181 Views

DOWNLOAD

REPORT


ORIGINAL ARTICLE – BREAST ONCOLOGY

Budget Impact Analysis of Preoperative Radioactive Seed Localization Wyanne Law, MD1 , Nicole Look Hong, MD, MSc, FRCPC2,3, Ananth Ravi, PhD, MCCPM4, Lisa Day, MRT (R), CBI5, Yasmin Somani, MRTNM6, Frances C. Wright, MD, MEd, FRCPC3, Sharon Nofech-Mozes, MD, FRCPC7,8, William T. Tran, MRT(T), MSc, PhD9, and Belinda Curpen, MD, FRCPC5 Postgraduate Department of Medical Imaging, University of Toronto, Toronto, ON, Canada; 2Evaluative Clinical Sciences, Odette Cancer Research Program, Sunnybrook Research Institute, Toronto, ON, Canada; 3Division of Surgical Oncology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada; 4Brachytherapy, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada; 5Breast Imaging, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; 6Nuclear Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; 7University of Toronto, Toronto, ON, Canada; 8Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; 9Radiation Oncology, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, ON, Canada 1

ABSTRACT Background. This study models costs in implementing a radioactive seed localization (RSL) program for nonpalpable breast lesions at a large Canadian tertiary hospital to replace existing wire-guided localization (WGL). Methods. All direct and indirect operating costs of localization per lesion from the hospital’s perspective were determined by retrospectively reviewing patient data and costs from January 2014 to December 2016. A budget impact analysis and sensitivity analysis were performed to calculate the mean cost per lesion, the minimum and maximum cost per lesion, operational costs, and initial costs. Results. There were 265 WGL lesions in 2014 and 170 RSL lesions in 2016 included in cost calculation. The mean cost per localization was $185 CAD for WGL ($148–$311) and $283 CAD ($245–$517) for RSL using preloaded seeds, adjusted to 2016 Canadian dollars. The annual operational expenditure including all localizations and

Ó Society of Surgical Oncology 2020 First Received: 21 May 2020 Accepted: 14 August 2020 W. Law, MD e-mail: [email protected]

overhead costs was $49,835 for WGL and $80,803 for RSL. Initial costs for RSL were $22,000, including external training and new equipment purchases. Conclusions. Our budget impact analysis shows that RSL using preloaded radioactive seeds was more expensive than WGL when considering per-lesion localization costs and specific costs related to radiation safety. Manually loading radioactive seed could be a cost-saving alternative to purchasing preloaded seeds. Our breakdown of costs can provide a framework for other centres to determine which localization method best suit their departments.

The implementation of breast cancer screening programs and novel imaging techniques have improved the detection rates of non-palpable breast lesions. Accurate localization of these lesions, either malignant or benign, is required for removal in t